Inhibition of β-glucuronidase in Human Urine by Ascorbic Acid
- 1 May 1990
- journal article
- research article
- Published by SAGE Publications in Human & Experimental Toxicology
- Vol. 9 (3) , 165-170
- https://doi.org/10.1177/096032719000900308
Abstract
The effects of oral supplementation of ascorbic acid (1500 mg d-1) on urinary β-glucuronidase (β-G) activity was assessed in a double-blind crossover study design over a 3-week period. The subjects on ascorbic acid treatment displayed a statistically significant (P < 0.05) decrease in β-G with an approximate decrease of 25%.Keywords
This publication has 5 references indexed in Scilit:
- The Crossover Experiment for Clinical TrialsBiometrics, 1980
- PROPOSED USES OF ASCORBIC ACID IN PREVENTION OF BLADDER CARCINOMA*Annals of the New York Academy of Sciences, 1975
- Clinical Application of 2, 5-DI-O-Acetyl-β-D-Glucaro-(1 →4) (6 → 3)-Dilactone (SLA) to the Bladder Tumor, with Special Reference to its Effect on Frequency of Tumor RecurrencesJournal of Urology, 1972
- Studies on β-glucuronidase. 2. The preparation and properties of three ox-spleen β-glucuronidase fractionsBiochemical Journal, 1953